atropine sulphate 1% ophthalmic
solution BID OS. RM was released
from the clinic and given instructions
for self-care at home. He was educated
to shake the bottle of topical steroid
before instillation. He was also given
a non-pressure eye patch to reduce
photophobia when outdoors or in
bright light only. In addition, the
patient was given a pair of clear
protective goggles to be worn during
sleep. He was instructed to sleep at an
angle of approximately 45 degrees, to
rest as much as possible, and to avoid
any strenuous activity. A follow-up
appointment was scheduled for 24
hours, and the patient was instructed to
return to clinic sooner if he developed
visual changes or increased pain